AMGNNEUTRAL

Revenue Growth (YoY)

5.8%

Higher than 46% of Healthcare sector peers

Updated 1879h ago

Sector Performance

46th percentile

AMGN

5.8%

Sector Median

6.2%

Sector Avg

4.2%

📊

Deep Analysis

Amgen's current revenue growth of 5.8% measures how much its sales increased compared to the same quarter one year ago, indicating modest top-line expansion.

This figure sits just below the healthcare sector median of 6.2%, placing Amgen at the 46th percentile among its peers—meaning slightly more than half of peer companies posted higher growth. Regarding trend, the year-over-year change, quarter-over-quarter change, and the last eight quarters of data are all listed as N/A, so no direction or momentum can be assessed. The combination of a near-median growth level with no available trend data neither signals a clear opportunity nor a specific risk, leaving the outlook ambiguous. This metric supports the overall NEUTRAL verdict, as the growth rate neither outperforms nor underperforms the sector meaningfully and lacks the trend information needed to shift the assessment.

Frequently Asked Questions

What does the Revenue Growth (YoY) tell investors about AMGN?

Year-over-year revenue acceleration is one of the strongest signals of business momentum. Sustained >15% growth is rare and typically re-rated by the market.

How is the Revenue Growth (YoY) calculated?

Revenue Growth (YoY) is calculated as: (Revenue_t - Revenue_t-4) / Revenue_t-4.

How does AMGN's Revenue Growth (YoY) compare to its sector?

AMGN's Revenue Growth (YoY) of 5.8% compares to a Healthcare sector median of 6.2%, placing it in the 46th percentile.

Who are AMGN's closest peers by Revenue Growth (YoY)?

The closest Healthcare peers by Revenue Growth (YoY) include: ALGN (6.2%), CPRX (5.6%), ABT (7.8%), ZBH (9.3%), A (10.0%).

The Formula

(Revenue_t - Revenue_t-4) / Revenue_t-4

Why It Matters

Year-over-year revenue acceleration is one of the strongest signals of business momentum. Sustained >15% growth is rare and typically re-rated by the market.